Anti-inflammatory reliever (AIR) is a single inhaler treatment for asthma which can be used by people with asthma and who experience asthma symptoms twice a week or less. It removes the need to have separate preventer (brown) and reliever (blue) inhalers.
On the 28th November the joint National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) will publish their long-awaited single guideline on asthma diagnosis, monitoring and management.
This document is a distillation of the new guidance to provide distinct advice on the changes on the diagnosis and management to asthma. It is not intended to be a comprehensive guide of the new guideline, neither does it cover all non-pharmacological treatments or on-going monitoring.
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Inhalation is the main route for administration of drugs for conditions such as asthma or chronic obstructive pulmonary disease. The advantage of administering drugs by inhaler is that drugs are delivered directly to the site of action within the airways.
Knowing how to use Very Brief Advice to instigate a quit attempt and supporting smokers who are ready to quit is the business of every healthcare professional.Treating tobacco dependency systematically and effectively will have a significant impact on the triple aim:
In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) in order to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 known as ‘Keeping it Simple’.
In this PCRS Health Inequalities podcast Leslie Borrill and Rebecca Jacobs discuss suicide and suicide prevention in long-term respiratory conditions. They cover:
In this PCRS Health Inequalities podcast Noreen Grant, Lisa Cummings and Aaron Foulds (PCRS patient reference group representative) talk about the impact of respiratory disease on mental health. They cover:
In this PCRS Health Inequalities podcast Katherine Hickman (PCRS executive chair, Kaniksha Aggarwal, Martin Sutcliffe and Sue Wheatcroft discuss respiratory disease and mental health in the context of the UK prison setting. They touch on:
This document outlines a consensus recommendation based on the best available evidence and expert opinion. Its purpose is to provide guidance on a safe approach within the limitations of the evidence and devices currently available.
Respiratory disease and mental health are interlinked in many ways, with respiratory conditions often impacting mental wellbeing and vice versa. NHS England states that people with severe and enduring mental illness are at greater risk of poor physical health and reduced life expect
Corinne Beirne, Advanced Nurse Practitioner and Amanda Roberts, from PCRS’s patient reference group, discuss what constitutes a good asthma review from a patient’s perspective.
2024 marked a pivotal change in the management of asthma in the UK with the publication of a joint British Thoracic Society (BTS), National Institute for Health and Care Excellence (NICE) and Scottish Intercollegiate Guidelines Network (SIGN) guideline.